Clinical and preclinical insights into a novel MDM2::PDGFRA fusion in recurrent glioblastoma
Abstract Glioblastoma is an aggressive and treatment-refractory primary brain tumor with limited therapeutic options and high recurrence. The molecular heterogeneity of glioblastoma poses a significant challenge to therapeutic development, as targeted therapies have mostly failed in small-scale clin...
Saved in:
| Main Authors: | Catherine Z. Beach, Christopher A. Febres-Aldana, Juan Luis Gomez Marti, Saeed Asiry, Tamika Wong, John A. Boockvar, Randy S. D’Amico, Romel Somwar, Monika A. Davare, Morana Vojnic |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-025-01076-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EGFR, p53, IDH-1 and MDM2 immunohistochemical analysis in glioblastoma: therapeutic and prognostic correlation
by: Richard Murdoch Montgomery, et al.
Published: (2015-07-01) -
Epstein-Barr virus nuclear antigen 1 (EBNA1) increases the expression levels of MDM2 and MDM4 genes in HeLa cells: a review on MDM2 and MDM4 roles in cancer
by: Seyed Mohammad Ali Hashemi, et al.
Published: (2025-05-01) -
Mechanistic Role of the Mdm2/MdmX Lid Domain in Regulating Their Interactions with p53
by: Qiuyin Wei, et al.
Published: (2025-04-01) -
Strategies for p53 Activation and Targeted Inhibitors of the p53-Mdm2/MdmX Interaction
by: Ye Huang, et al.
Published: (2025-04-01) -
Single-cell transcriptomics identifies PDGFRA+ progenitors orchestrating angiogenesis and periodontal tissue regeneration
by: Jianing Liu, et al.
Published: (2025-07-01)